What You Should Know:
OXOS Medical, the MedTech innovator developing simple and safe X-ray solutions, announced a $23 million Series A funding from Parkway Venture Capital and Intel Capital, bringing its total funding to $45 million.OXOS continues to build on its traction across outpatient clinics, the military, the Veterans Administration, sports teams, hospitals, imaging centers, and bioskills labs. To help accelerate the company’s growth, Gregg Hill, Parkway Venture Capital co-founder and
Read More
intel
Intel Labs & Penn Medicine Uses Privacy-Preserving AI to Identify Brain Tumors
What You Should Know:
- Intel Labs and the Perelman School of Medicine at the University of Pennsylvania (Penn Medicine) have completed a joint research study using federated learning – a distributed machine learning (ML) artificial intelligence (AI) approach – to help international healthcare and research institutions identify malignant brain tumors.
- The largest medical federated learning study to date with an unprecedented global dataset examined from 71 institutions across six
Read More
The Gains and Pains of Using AI in the Pharmaceutical Industry
The costs for drug discovery and development are skyrocketing, but AI (artificial intelligence) is introducing new efficiencies to help find effective treatments faster.
A study in 2020 concluded that the estimated median capitalized research and development cost per product was $985 million. Contributing factors to this included larger trial sizes, the need to assess health technology, the requirement to provide data on comparative drugs’ effectiveness, and most
Read More
Intel Invests $20M in Biofourmis’ Virtual Care Offerings
What You Should Know:
- Biofourmis, a Boston-based global leader in virtual care and digital medicine, today announced that Intel Capital, the strategic investment arm of chipmaker Intel Corporation, has joined its Series D financing in an extension that brings the total funding raised in the round to $320M.
- The initial Series D funding round was announced in April and was led by global growth equity firm General Atlantic with participation by CVS Health (NYSE:CVS), Trevor
Read More
Intel & Sheba Partner to Develop AI Solution to Improve Detection of Crohn’s Disease
What You Should Know:
- Sheba Medical Centre, Israel’s largest medical center, today announced a collaboration with Intel Corporation to help doctors improve the diagnosis and treatment of people with Crohn's disease.
- Sheba developed a new, first-of-its-kind application capable of quickly and accurately analyzing extensive video data of a patient’s digestive system, providing valuable insights to aid medical professionals.
AI-driven Solutions to Diagnose Crohn’s Disease
The
Read More
BeeKeeperAI Partners with Microsoft to Accelerate AI-Powered Innovation in Healthcare
What You Should Know:
- BeeKeeperAI, a company powering AI-powered solutions that will help to redefine the future of healthcare today announced its expanded collaboration with Microsoft.
- The collaboration will allow algorithm developers and healthcare data stewards to access BeeKeeperAI, operating in the Microsoft Azure confidential computing (ACC) environment, through the Azure Marketplace.
New Frontier for Healthcare AI Research
The enhanced collaboration aims to accelerate the
Read More
Biofourmis Secures $300M to Expand Virtual Care Offerings
What You Should Know:
- Biofourmis, a global leader in virtual care and digital medicine raises $300 million in Series D investment led by leading global growth equity firm General Atlantic. CVS Health and existing investors also participated in the round,
- Biofourmis also announced that former Medtronic CEO and Chairperson at Intel, Dr. Omar Ishrak, will join the company’s Board of Directors as Chairman.
Transforming Patient Health Through Personalized, Predictive Care
Founded in
Read More
DiA Imaging Analysis Partners with Intel to Improve Ultrasound Analysis by 40%
What You Should Know:
- DiA Imaging Analysis Ltd, a global provider of AI-powered ultrasound analysis software, has teamed up with Intel to streamline artificial intelligence (AI) solutions used by echocardiography (Echo) labs.
- DiA’s AI-based software, LVivo Seamless™, automatically analyzes cardiac ultrasound images using the Intel® Distribution of OpenVINO™ toolkit, to optimize processing time by over 40% percent while maintaining accuracy.
Accelerating Processing Times for AI-Based
Read More
VDI: Promising Approach for Healthcare IT to Ease Endpoint Management?
Healthcare IT has always faced unique challenges.
Among these challenges are the increasing mobility of healthcare workers. Healthcare providers are always on the move throughout hospitals. Still, they need to access the same apps and data, and their own unique workspace, wherever they are, quickly and securely.
Additionally, strict legal requirements and internal policies govern exactly how confidential patient data can be stored and accessed. Not to mention the need for
Read More
Intel, Samsung Partner on AI-Based Ultrasound Solution for Anesthesia Administration
What You Should Know:
- Samsung Medison and Intel are collaborating on NerveTrack™, a real-time nerve tracking ultrasound feature that helps anesthesiologists identify nerves in a patient’s arm to help administer anesthesia quickly and accurately. Leveraging the Intel Distribution of OpenVINO toolkit for computer vision and annotation, Samsung Medison’s NerveTrack™ can reduce scanning time by up to 30 percent in an extremely
Read More
